Clinical Trials Directory

Trials / Unknown

UnknownNCT02413437

A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms

The Multi-center Study of Percutaneous Focal Liver Lesions Biopsy Guided by Contrast-Enhanced Ultrasound

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
2,088 (estimated)
Sponsor
Peking University Cancer Hospital & Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to estimate the clinical value of contrast-enhanced ultrasound in percutaneous biopsy for liver occupied lesion.

Detailed description

The patients with liver neoplasms who need receive percutaneous biopsy were randomized into contrast-enhanced ultrasound(CEUS) group and conventional ultrasound(US) group.The aims include: 1. Comparison the diagnostic accuracy rate, specificity and sensitivity between CEUS and US group. 2. Comparison the diagnostic accuracy rate specificity and sensitivity between smaller(\<3cm) and larger(≥3cm) nodule group. 3. To explore operating strategy of contrast-enhanced ultrasound guided biopsy. 4. To evaluate economic efficiency of contrast-enhanced ultrasound guided biopsy compared with conventional ultrasound guided biopsy.

Conditions

Interventions

TypeNameDescription
OTHERCEUS guided biopsyBiopsy was operated under contrast-enhanced ultrasound-guided.
OTHERUS guided biopsyBiopsy was operated under conventional ultrasound-guided.
DEVICEUltrasound

Timeline

Start date
2015-04-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2015-04-09
Last updated
2017-05-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02413437. Inclusion in this directory is not an endorsement.